← Eichor
Condition: Cmv Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cmv Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Phase 2 · 9 location(s) · New York Medical College · NCT03266640Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07477925Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infec
Phase 1/Phase 2 · 1 location(s) · LucasBio · NCT07670468Third Party Viral Specific T-cells (VSTs)
Phase 2 · 4 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02532452Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
Phase 1/Phase 2 · 2 location(s) · Catherine Bollard · NCT03594981A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · 29 location(s) · Children's Oncology Group · NCT05711667A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731Overview of Targeted Screening for Congenital Infection Guided by Neonatal Hearing Screening
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07335874A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment
Phase 3 · 53 location(s) · Takeda · NCT05319353TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Phase 1 · 2 location(s) · Baylor College of Medicine · NCT04013802A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea
Phase N/A · 1 location(s) · Takeda · NCT06555432Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
Phase 4 · 12 location(s) · WeiShi · NCT07569653Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections
Phase 3 · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06334497Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
EARLY_Phase 1 · 1 location(s) · Tianjin Medical University · NCT05911503Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Str
Phase 3 · 1 location(s) · University Hospital, Rouen · NCT05708508Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus S
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05101213Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lu
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07235683A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
Phase 2 · 11 location(s) · SymBio Pharmaceuticals · NCT04706923Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Phase N/A · 23 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05234723Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection
Phase N/A · 2 location(s) · Rigshospitalet, Denmark · NCT07635368Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Phase N/A · 5 location(s) · MSD Italia S.r.l. · NCT06916195Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Cent
NA · 1 location(s) · National Taiwan University Hospital · NCT07294547T Cell Therapy of Opportunistic Cytomegalovirus Infection
EARLY_Phase 1 · 1 location(s) · Mari Dallas · NCT02982902Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
Phase 3 · 33 location(s) · Tobias Feuchtinger · NCT04832607CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Unde
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06059391Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection
Phase N/A · 1 location(s) · Takeda · NCT06577363Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Rel
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06058858Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT
Phase 3 · 1 location(s) · Ruijin Hospital · NCT07511127CMV-CMI in csCMVi After HSCT
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07688759
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.